After the in vitro stimulation of isolated tumor-infiltrating CD8+ T cells by the peptide pool, there was a significant increase in spot forming cells (SFCs) in both the RSL- and anti-PD-1-treated groups, while the combination of RSL and anti-PD-1 achieved the greatest percentage of SFCs (Figure 6A). This evidence concerns the gene PDCD1 and neoplasm.